Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine
Launched by HOPITAL CHARLES NICOLLE · Jul 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to manage low blood pressure (hypotension) that can occur after spinal anesthesia during elective cesarean sections. Researchers want to compare two treatments: diluted norepinephrine and ephedrine. Both are medications used to help raise blood pressure, but norepinephrine may have fewer side effects for mothers and their babies. The goal is to find out which treatment works better in keeping blood pressure stable during and after the surgery.
To participate in this study, women aged 18 to 38 who are having a planned cesarean section under spinal anesthesia may be eligible. Participants will be randomly assigned to receive either norepinephrine or ephedrine after their anesthesia is given. Throughout the procedure, their blood pressure and heart rate will be closely monitored, and any side effects will be recorded. This study aims to improve the safety of cesarean sections for both mothers and their newborns.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton full-term consenting pregnant females of ASA grade II, aged 18-38 years, scheduled for elective cesarean section under spinal anesthesia
- Exclusion Criteria:
- • Any parturient falling in the category ASA grade III and IV, contrindications to spinal anesthesia, preeclampsia, chronic hypertension, comorbidity with diabetes mellitus, cardiovascular disorders and psychiatric illness are non included.
- • They are excluded the case of failure of spinal anesthesia, conversion to general anesthesia, post-partum bleeding, and failure to follow protocol.
About Hopital Charles Nicolle
The Hospital Charles Nicolle is a leading healthcare institution dedicated to providing exceptional medical care and advancing clinical research. Located in Tunisia, it serves as a pivotal center for patient care, education, and innovation in the medical field. With a commitment to improving health outcomes, the hospital actively sponsors and conducts clinical trials across various specialties, facilitating the development of new therapies and treatment modalities. Its multidisciplinary team of healthcare professionals collaborates closely with researchers and regulatory bodies to ensure the highest standards of safety and efficacy in clinical research, ultimately aiming to enhance patient care and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, , Tunisia
Patients applied
Trial Officials
Alia Jebri, MD
Study Director
Charles Nicolle Hospital Tunis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported